Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound) in adults with BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity
Some tablets have higher doses for faster effects, but it is always advisable to consult a doctor before taking higher doses
Nutrient sensing in the gut: interactions between chemosensory cells, visceral afferents and the secretion of satiation peptides
Yes, it is possible to switch from semaglutide GLP-1 to tirzepatide for weight loss, but it should only be done under the guidance of a healthcare provider
PMID 7844111
US$ 28.84
US$ 22.22
US$ 29.33
US$ 26.98
